Ebberink Eduard H T M, Bouwens Eveline A M, Bloem Esther, Boon-Spijker Mariëtte, van den Biggelaar Maartje, Voorberg Jan, Meijer Alexander B, Mertens Koen
Department of Plasma Proteins, Sanquin Research, Amsterdam, the Netherlands.
Landsteiner Laboratory of AMC and Sanquin, University of Amsterdam, the Netherlands.
Haematologica. 2017 Apr;102(4):686-694. doi: 10.3324/haematol.2016.153163. Epub 2017 Jan 5.
Factor VIII C-domains are believed to have specific functions in cofactor activity and in interactions with von Willebrand factor. We have previously shown that factor VIII is co-targeted with von Willebrand factor to the Weibel-Palade bodies in blood outgrowth endothelial cells, even when factor VIII carries mutations in the light chain that are associated with defective von Willebrand factor binding. In this study, we addressed the contribution of individual factor VIII C-domains in intracellular targeting, von Willebrand factor binding and cofactor activity by factor VIII/V C-domain swapping. Blood outgrowth endothelial cells were transduced with lentivirus encoding factor V, factor VIII or YFP-tagged C-domain chimeras, and examined by confocal microscopy. The same chimeras were produced in HEK293-cells for characterization and chemical foot-printing by mass spectrometry. In contrast to factor VIII, factor V did not target to Weibel-Palade bodies. The chimeras showed reduced Weibel-Palade body targeting, suggesting that this requires the factor VIII C1-C2 region. The factor VIII/V-C1 chimera did not bind von Willebrand factor and had reduced affinity for activated factor IX, whereas the factor VIII/V-C2 chimera showed a minor reduction in von Willebrand factor binding and normal interaction with activated factor IX. This suggests that mainly the C1-domain carries factor VIII-specific features in assembly with von Willebrand factor and activated factor IX. Foot-printing analysis of the chimeras revealed increased exposure of lysine residues in the A1/C2- and C1/C2-domain interface, suggesting increased C2-domain mobility and disruption of the natural C-domain tandem pair orientation. Apparently, this affects intracellular trafficking, but not extracellular function.
人们认为凝血因子VIII的C结构域在辅因子活性以及与血管性血友病因子的相互作用中具有特定功能。我们之前已经表明,即使凝血因子VIII轻链携带与血管性血友病因子结合缺陷相关的突变,它仍与血管性血友病因子共同靶向血液生成内皮细胞中的魏尔-帕拉德小体。在本研究中,我们通过凝血因子VIII/V C结构域交换来探讨各个凝血因子VIII C结构域在细胞内靶向、血管性血友病因子结合和辅因子活性中的作用。用编码凝血因子V、凝血因子VIII或YFP标记的C结构域嵌合体的慢病毒转导血液生成内皮细胞,并通过共聚焦显微镜检查。在HEK293细胞中产生相同的嵌合体,用于质谱表征和化学足迹分析。与凝血因子VIII不同,凝血因子V不靶向魏尔-帕拉德小体。嵌合体显示魏尔-帕拉德小体靶向性降低,这表明这需要凝血因子VIII的C1-C2区域。凝血因子VIII/V-C1嵌合体不结合血管性血友病因子,对活化的凝血因子IX的亲和力降低,而凝血因子VIII/V-C2嵌合体显示血管性血友病因子结合略有降低,与活化的凝血因子IX的相互作用正常。这表明主要是C1结构域在与血管性血友病因子和活化的凝血因子IX组装中具有凝血因子VIII特异性特征。对嵌合体的足迹分析显示,A1/C2和C1/C2结构域界面中的赖氨酸残基暴露增加,表明C2结构域的流动性增加,天然C结构域串联对方向被破坏。显然,这影响细胞内运输,但不影响细胞外功能。